Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc.
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its...
Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 19, 2024 4:13pm
@ the Bell: Markets deeply divided amid Middle East flareup
Canada’s main stock index jumped on Friday, aiming to recoup some weekly losses, as investors shed caution around Middle East tensions.
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 4:17pm
@ the Bell: TSX keeps it just above the flatline
Driven by materials stocks tracking higher metals prices, utilities led gainers on the TSX while energy and industrials led the drop.
read article.
Coelacanth Announces 2023 Year-End Reserves
posted Apr 19, 2024 9:00am by
Coelacanth Energy Inc.
-
|
During 2023, Coelacanth completed successful Montney pad wells at both Two Rivers West and Two Rivers East. Longer wells and a new completion design was successfully executed on both pads resulting in materially improved productivity. Baseline productivity was established in the Upper Montney at Two Rivers West and the Lower and Basal Montney at Two Rivers East for future adjustments to completions and well designs ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 5:00am
Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions
Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.
read article.
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 17, 2024 6:25pm
RE:Kane Biotech to Host Investor Webinar
These volumes haven't been seen for a while and cannot be ignored and I see it as a positive sign. I like to think it as some one taking an active interest and a substantial initial position
...more
(1887)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 16, 2024 6:59pm
Kane Biotech to Host Investor Webinar
WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 16, 2024 9:15am
New Press Release - Kane Biotech to Host Investor Webinar
What the sale of STEM Animal Health means for Kane going forward – Thursday April 18th, 2024 at 4:15pm Eastern Time WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024...
read article.
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 15, 2024 12:58pm
RE:RE:RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
1.71 M shares traded @ .12 at open today is interesting timing.
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 15, 2024 12:54pm
RE:RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
Right. Thank you for that.
(341)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Apr 15, 2024 12:40pm
RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
No dilution, STEM was a Kane's subsidiary so Dechra bought 100% of STEM's shares 1/3 from Ecuphar NV (Animalcare) and 2/3 from Kane.
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 15, 2024 11:49am
RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
Did this transaction result in dilution and a loss of STEM in order to get proceeds.?. here is why I ask, "The Transaction was completed by way of a share purchase agreement between Kane, STEM
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 15, 2024 9:15am
New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
An important step in Kane becoming a market leader in the growing high-value wound care and dermatological markets WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that, it has completed the sale of its interest in STEM Animal...
read article.
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 12, 2024 3:14pm
RE:So clearly
Profitably would do it.
(341)
•••
RoyMax123
X
View Profile
View Bullboard History
Post by
RoyMax123
on Apr 12, 2024 1:07pm
So clearly
The market was expecting more... sadly we'll probalby go back in the .10-.12 range for several months
(69)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 11, 2024 12:45pm
RE:RE:RE:RE:New Press Release - Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
Marc wanted a little financial breathing room and the amount is solid. Paying off the high interest loan is smart and hopefully we can accelerate some revenues as everyone says rather than take
...more
(99)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Apr 11, 2024 12:08pm
RE:RE:RE:New Press Release - Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
STEM Animal was sold to Dechra Pharmaceuticals. An interesting point to note is that Kane/Animalcare and Dechra will jointly developed new products for the animal health market. Link to Animalcare
...more
(99)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Apr 11, 2024 11:08am
RE:RE:New Press Release - Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
Agree with you, it is a good/fair deal. The fact that they've paid Pivot Financials is a very good news. Now the interesting part of the story starts; 1. Revyve sales in the USa as well as
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 11, 2024 10:01am
New Press Release - Canadian Investment Regulatory Organization Trade Resumption - KNE
VANCOUVER, BC, April 11, 2024 /CNW/ - Trading resumes in:Company: Kane Biotech Inc.TSX-Venture Symbol: KNEAll Issues: YesResumption (ET): 10:30 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented...
read article.
(341)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Apr 11, 2024 9:58am
RE:New Press Release - Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
That's an good deal but nothing more, they will have enough cash for about 2 or 3 quarter. They keep the dev which will get them a bit a revenue, now let hope that they will finnaly launch the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors
The Increasing Investments by the Defense and Military Sectors is Driving the Demand for Helium
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%